Anila Lingamneni, EVP, Chief Technology Officer at HAEMONETICS CORP (HAE), sold 2,215 shares at $90.00 ($199K) on 2024-07-11, disclosed to the SEC on 2024-07-15.
Scheduled sale ($199k) by EVP, Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.00 | 2,136 | $192K | 96.4% |
| 2 | $90.00 | 79 | $7K | 3.6% |
| Total | $90.00 avg | 2,215 | $199K | 100% |
| Filing → |
| HAE | SELL | 2023-06-01 | $384K | — | Filing → |
| HAE | SELL | 2022-05-23 | $164K | — | Filing → |
| HAE | SELL | 2022-04-19 | $11K | — | Filing → |